Advances in stroke prevention

Publisher： John Wiley & Sons Inc

E-ISSN： 1749-6632|1338|1|1-15

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1338, Iss.1, 2015-03, pp. : 1-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke

By Kikuchi Kiyoshi   Uchikado Hisaaki   Morioka Motohiro   Murai Yoshinaka   Tanaka Eiichiro  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-06 ,pp. : 7739-7761

MDPI

Access to resources Recommend Favorite

Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation

By Stöllberger Claudia   Finsterer Josef  

Pharmaceuticals, Vol. 5, Iss. 2, 2012-02 ,pp. : 155-168

MDPI

Access to resources Recommend Favorite

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines

By Armaganijan Luciana   Patel Dimpi   Dietrich Cristiano   Morillo Carlos A.  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 384-397

MDPI

Access to resources Recommend Favorite

Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications

By  

CNS: NEUROSCIENCE AND THERAPEUTICS, Vol. 21, Iss. 11, 2015-11 ,pp. : 870-876

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke

By Kikuchi Kiyoshi   Tancharoen Salunya   Ito Takashi   Morimoto-Yamashita Yoko   Miura Naoki   Kawahara Ko-ichi   Maruyama Ikuro   Murai Yoshinaka   Tanaka Eiichiro  

International Journal of Molecular Sciences, Vol. 14, Iss. 9, 2013-09 ,pp. : 18899-18924

MDPI

Access to resources Recommend Favorite